To pull off a defense win in a product liability case, it’s crucial to have a judge willing to block damaging evidence from the jury. Contrasting jury verdicts in two recent trials over Prempro the menopause relief drug from Pfizer that has been linked to breast cancer prove that point.
A federal jury in Bridgeport, Connecticut, last week found Pfizer subsidiary Wyeth Pharmaceuticals isn’t liable for the 2006 death from breast cancer of a 62-year-old nurse who used Prempro. The verdict came after four weeks of trial and just five hours of deliberation. Louisville, Kentucky-based Bubalo Rotman represented the plaintiff. Pfizer was represented by Kaye Scholer partners Pamela Yates and Andrew Solow, as well as David Dukes of Nelson, Mullins, Riley & Scarborough, and Kelly Evans of Snell & Wilmer.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
